Clinical trial • Phase I • Respiratory

pembrolizumab for Non-squamous non-small cell lung cancer (advanced or metastatic)

Phase I trial of pembrolizumab for Non-squamous non-small cell lung cancer (advanced or metastatic).

Overview

Trial Therapeutic Area
Respiratory
Trial Disease
Non-squamous non-small cell lung cancer (advanced or metastatic)
Trial Stage
Phase I
Drug Modality
Monoclonal antibody

Key dates

Initial CTIS Submission Date
31-05-2024
First CTIS Authorization Date
25-09-2024

Trial design

Keytruda (pembrolizumab); dose and schedule not specified-controlled Phase I trial across 56 sites in France, Bulgaria, Austria and others.

Comparator
Keytruda (pembrolizumab); dose and schedule not specified
Target Sample Size
652

Recruitment

Planned Sample Size
652
Recruitment Window Months
49

Geography

Total Number Of Sites
56
Total Number Of Participants
233

France

Earliest CTIS Part Ii Submission Date
19-08-2024
Latest Decision Or Authorization Date
04-02-2026
Processing Time Days
534
Number Of Sites
9
Number Of Participants
14

Sites

Site Name
Centre Hospitalier Intercommunal Toulon / La Seine-Sur-Mer
Department Name
Pneumology
Contact Person Name
Clarisse Audigier-Valette
Site Name
Hopital Europeen Marseille
Department Name
Pneumology
Contact Person Name
Jacques LeTreut
Contact Person Email
j.letreut@hopital-europeen.fr
Site Name
Centre Hospitalier Universitaire De Bordeaux
Department Name
Medical Oncology
Contact Person Name
Charlotte Domblides
Site Name
Assoc Hospitaliere Nord Artois Clinique
Department Name
Pneumology
Contact Person Name
Geoffrey Pavaut
Contact Person Email
mfery@ahnac.com
Site Name
Centre Hospitalier Universitaire De Nantes
Department Name
Oncology thoracic Unit
Contact Person Name
Elvire Pons-Tostivinit
Contact Person Email
elvire.pons@chu-nantes.fr
Site Name
Centre De Cancerologue Du Grand Montpellier
Department Name
Pneumology
Contact Person Name
Catherine Becht
Contact Person Email
becht@ccgm.fr
Site Name
Centre Hospitalier Universitaire De Nimes
Department Name
Oncology
Contact Person Name
Sylvie Van Hulst
Contact Person Email
sylvie.vanhulst@chu-nimes.fr
Site Name
Centre Hospitalier Et Universitaire De Limoges
Department Name
Pneumology
Contact Person Name
Thomas Egenod
Contact Person Email
thomas.egenod@chu-limoges.fr
Site Name
Hopitaux Prives De Metz
Department Name
Pneumology
Contact Person Name
Julie Perrin
Contact Person Email
julie.perrin@uneos.fr

Bulgaria

Earliest CTIS Part Ii Submission Date
26-08-2024
Latest Decision Or Authorization Date
09-02-2026
Processing Time Days
532
Number Of Sites
3
Number Of Participants
7

Sites

Site Name
University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD
Department Name
Department of Medical Oncology
Contact Person Name
Bozhil Robev
Contact Person Email
bostro@abv.bg
Site Name
Multiprofile Hospital For Active Treatment Dobrich AD
Department Name
Department of Medical Oncology
Contact Person Name
Zyuhal Kasimova
Contact Person Email
dr.zyuhal.kasimova@gmail.com
Site Name
UMHAT Sofiamed OOD
Department Name
Department of Medical Oncology
Contact Person Name
Velko Minchev
Contact Person Email
V_minchev@abv.bg

Austria

Earliest CTIS Part Ii Submission Date
19-07-2024
Latest Decision Or Authorization Date
09-02-2026
Processing Time Days
570
Number Of Sites
3
Number Of Participants
12

Sites

Site Name
Ordensklinikum Linz GmbH
Department Name
Pneumology
Contact Person Name
Michael Schumacher
Site Name
Klinik Hietzing
Department Name
Klinik Hietzing 5. Med. Abteilung Pavillon 3
Contact Person Name
Alexander Kavina
Site Name
Landeskrankenanstalten-Betriebsgesellschaft Kabeg
Department Name
Department of pulmonary diseases
Contact Person Name
Barbara Mittergradnegger

Spain

Earliest CTIS Part Ii Submission Date
23-08-2024
Latest Decision Or Authorization Date
06-02-2026
Processing Time Days
532
Number Of Sites
16
Number Of Participants
57

Sites

Site Name
Hospital Universitario Central De Asturias
Department Name
Oncology
Contact Person Name
Emilio Esteban Gonzalez
Contact Person Email
eestebang@seom.org
Site Name
Micancer Center S.L.P.
Department Name
Oncology
Contact Person Name
Santiago Viteri Ramirez
Contact Person Email
sviteri@uomi.es
Site Name
Consorci Sanitari Del Maresme
Department Name
Oncology
Contact Person Name
Laura Punti Brun
Contact Person Email
lpunti@csdm.cat
Site Name
Hospital Quironsalud Valencia
Department Name
Oncology
Contact Person Name
Francisco Aparisi Aparisi
Site Name
Hospital Universitario Virgen De Valme
Department Name
Oncology
Contact Person Name
José Fuentes Pradera
Contact Person Email
fuentespradera@hotmail.com
Site Name
Hospital General Universitario De Elche
Department Name
Oncology
Contact Person Name
Asia Ferrández Arias
Contact Person Email
asiaariasf@gmail.com
Site Name
Hospital Quironsalud Barcelona
Department Name
Oncology
Contact Person Name
María Florencia García Casabal Cid
Contact Person Email
florencia.garcia@iob-onco.com
Site Name
Hospital Quironsalud Malaga
Department Name
Oncology
Contact Person Name
Manuel Cobo Dols
Contact Person Email
Manuel.cobo.co@quironsalud.es
Site Name
University Hospital Virgen Del Rocio S.L.
Department Name
Oncology
Contact Person Name
María de los Reyes Bernabe Caro
Site Name
Hospital Universitario Y Politecnico La Fe
Department Name
Oncology
Contact Person Name
Oscar José Juan Vidal
Contact Person Email
Juan_osc@gva.es
Site Name
Hospital Universitario De Jaen
Department Name
Oncology
Contact Person Name
Ana Laura Ortega Granados
Contact Person Email
oncojaen@fibao.es
Site Name
Instituto Multidisciplinar De Oncologia S.A.
Department Name
Oncology
Contact Person Name
Esther Holgado Martín
Contact Person Email
esther.holgado@genesiscare.es
Site Name
Hospital Clinico Universitario De Valladolid
Department Name
Oncology
Contact Person Name
Rafael López Castro
Contact Person Email
rlopezc@saludcastillayleon.es
Site Name
Hospital Universitario Fundacion Alcorcon
Department Name
Oncology
Contact Person Name
Elisabeth Jimenez Aguilar
Site Name
Hospital Clinico San Carlos
Department Name
Oncology
Contact Person Name
Carlos Aguado De La Rosa
Site Name
Hospital Universitario Fundacion Jimenez Diaz
Department Name
Oncology
Contact Person Name
Manuel Domine Gomez
Contact Person Email
mdomine@fjd.es

Italy

Earliest CTIS Part Ii Submission Date
04-09-2024
Latest Decision Or Authorization Date
04-02-2026
Processing Time Days
518
Number Of Sites
11
Number Of Participants
53

Sites

Site Name
Azienda Ospedaliera Universitaria Universita' Degli Studi Della Campania Luigi Vanvitelli
Department Name
UOC Oncoematologia
Contact Person Name
Carmina Maria Della Corte
Site Name
San Camillo Forlanini Hospital
Department Name
UOSD Pneumo- oncologia
Contact Person Name
Giuditta Di Isernia
Site Name
Azienda Socio Sanitaria Territoriale Di Cremona
Department Name
Oncologia
Contact Person Name
Stefano Panni
Contact Person Email
Stefano.panni@asst-cremona.it
Site Name
Azienda Sanitaria Locale Napoli 1 Centro
Department Name
UOC Oncologia
Contact Person Name
Bruno Daniele
Site Name
Azienda Socio Sanitaria Territoriale Della Valtellina E Dell Alto Lario
Department Name
SC Oncologia Medica
Contact Person Name
Ornella Fusco
Contact Person Email
ornella.fusco@asst-val.it
Site Name
Azienda Ospedaliera S Maria Di Terni
Department Name
S.C. Oncologia Medica
Contact Person Name
Cristina Zannori
Contact Person Email
c.zannori@aospterni.it
Site Name
Fondazione IRCCS Ca Granda Ospedale Maggiore Policlinico
Department Name
SC Oncologia Medica
Contact Person Name
Claudia Maria Regina Bareggi
Site Name
University Hospital Of Ferrara
Department Name
UO Oncologia
Contact Person Name
Luana Calabrò
Contact Person Email
Luana.calabro@unife.it
Site Name
Azienda Unita Sanitaria Locale Della Romagna
Department Name
UO Oncologia, Dipartimento Onco-Ematologico
Contact Person Name
Manolo D’Arcangelo
Site Name
San Camillo Forlanini Hospital (additional/contact)
Department Name
UOSD Pneumo- oncologia
Site Name
Other Italian participating hospitals (listed in CTIS)

Poland

Earliest CTIS Part Ii Submission Date
09-09-2024
Latest Decision Or Authorization Date
08-02-2026
Processing Time Days
517
Number Of Sites
7
Number Of Participants
60

Sites

Site Name
Centrum Onkologii Im. Prof. Franciszka Lukaszczyka W Bydgoszczy
Department Name
Ambulatorium Chemioterapii I
Contact Person Name
Bogdan Zurawski
Site Name
Warminsko-Mazurskie Centrum Chorob Pluc W Olsztynie
Department Name
Oddzial onkologii z pododdzialem chemioterapii
Contact Person Name
Jaroslaw Kolb-Sielecki
Contact Person Email
psocha@pulmonologia.olsztyn.pl
Site Name
Med Polonia Sp. z o.o.
Department Name
not applicable/nie dotyczy
Contact Person Name
Rodryg Ramlau
Site Name
Wojewodzki Szpital Specjalistyczny Im. Janusza Korczaka W Slupsku Sp. z o.o.
Department Name
Oddział Onkologii Klinicznej, Chemioterapii
Contact Person Name
Wojciech Rogowski
Contact Person Email
tymoteusz.czujko@gmail.com
Site Name
Uniwersytecki Szpital Kliniczny Nr 4 W Lublinie
Department Name
Kliniczny Oddzial Pneumonologii, Alergologii, Onkologii Pulmonologicznej i Chorob Wewnetrznych
Contact Person Name
Janusz Milanowski
Site Name
Niepubliczny Zaklad Opieki Zdrowotnej Neuromed M. I M. Nastaj. sp.p.
Contact Person Name
Tomasz Jankowski
Contact Person Email
neuromed.lublin@gmail.com
Site Name
Other Polish participating centres (listed in CTIS)

Germany

Earliest CTIS Part Ii Submission Date
19-07-2024
Latest Decision Or Authorization Date
03-02-2026
Processing Time Days
563
Number Of Sites
7
Number Of Participants
30

Sites

Site Name
Onkologie UnterEms
Contact Person Name
Lothar Müller
Contact Person Email
info@onkologie-ue.de
Site Name
Klinikum St Marien Amberg
Contact Person Name
Ludwig Fischer von Weikersthal
Site Name
Justus-Liebig-Universitaet Giessen
Department Name
Hämatologie und Internistische Onkologie
Contact Person Name
Thomas Wehler
Site Name
KEM I Evang. Kliniken Essen-Mitte gGmbH
Department Name
Klinik für Internistische Onkologie &Onkologische Palliativmedizin
Contact Person Name
Sebastian W. Ertl
Contact Person Email
onkologie@kem-med.com
Site Name
Klinikum Aschaffenburg-Alzenau gGmbH
Contact Person Name
Manfred Welslau
Site Name
Dr. Vehling-Kaiser MVZ GmbH
Contact Person Name
Ursula Vehling-Kaiser
Contact Person Email
studien@vehling-keiser.de
Site Name
Friedrich-Ebert-Krankenhaus Neumuenster GmbH
Department Name
Klinik Hämatologie, Onkologie und Nephrologie
Contact Person Name
Siegfried Haas
Contact Person Email
siegfried.haas@fek.de

Sponsor

Primary sponsor

Full Name
Amgen Inc.
Organisation Type
Pharmaceutical company
Country Of Registered Address
United States

Investigational products

Investigational Product Name
ABP 234
Active Substance
pembrolizumab
Modality
Monoclonal antibody
Routes Of Administration
Intravenous
Route
Intravenous
Investigational Product Name
Keytruda (pembrolizumab)
Active Substance
pembrolizumab
Modality
Monoclonal antibody
Routes Of Administration
Intravenous
Route
Intravenous
Authorisation Status
Authorised product (reference)

Related trials

Other published trials that may interest you.